Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
161.4 USD | +3.22% | -1.36% | +30.09% |
Business Summary
Number of employees: 229
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 0 | nan % | 51 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 51 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 16-04-14 | |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Trevor Parry
CTO | Chief Tech/Sci/R&D Officer | - | - |
George Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Meg Dodge
IRC | Investor Relations Contact | - | - |
Hubert Chen
PRN | Corporate Officer/Principal | - | - |
John Thomas
LAW | General Counsel | - | 21-08-31 |
Nate Rattner
AUD | Comptroller/Controller/Auditor | - | - |
John Karakkal
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 16-10-31 |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Dino Rossi
BRD | Director/Board Member | 69 | 17-05-31 |
Chief Executive Officer | 59 | 16-04-14 | |
Julian Gangolli
BRD | Director/Board Member | 66 | 19-02-28 |
Director/Board Member | 57 | 17-08-31 | |
E. Sutherland
BRD | Director/Board Member | 54 | 22-01-17 |
Director/Board Member | 66 | 21-01-03 | |
Director/Board Member | 59 | 23-03-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,558,440 | 24,915,115 ( 87.24 %) | 0 | 87.24 % |
Company contact information
Krystal Biotech, Inc.
2100 Wharton Street Suite 701
15203, Pittsburgh
+412 586 5830
http://www.krystalbio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.09% | 4.62B | |
+8.92% | 114B | |
+10.48% | 105B | |
-1.83% | 21.73B | |
-6.45% | 23.83B | |
-10.39% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- KRYS Stock
- Company Krystal Biotech, Inc.